
Tuscan Village Drops Biotech for Mix of Uses
With the life science real estate market in free-fall, the last phase of a big development just over the New Hampshire line has a new plan.
With the life science real estate market in free-fall, the last phase of a big development just over the New Hampshire line has a new plan.
A new real estate platform by Bain Capital Real Estate that specializes in biomanufacturing projects acquired a Bedford property for $26.35 million as its first investment.
Alexandria bought the huge facility in early 2022 as part of a $341 million, eight-property deal to take advantage of drugmaking demand that never materialized.
The free-flowing funding climate in biotech slowed to a trickle in 2022, choking off the supply of tenants to fill Boston’s explosion of new life science real estate.
Massachusetts lost biomanufacturing jobs last year, raising questions about the sector’s future in the state. But local and state leaders are planning initiatives to show the Bay State remains a formidable powerhouse.
Massachusetts’ life science industry added R&D jobs but lost traction in biomanufacturing, a hoped-for source of new jobs and economic growth outside of the Greater Boston cluster.
Following the recent pause of a high-profile biomanufacturing project in Worcester, a central Massachusetts incubator laid out a growth strategy for the industry cluster.
Two Democrats who have a chance to stamp their mark on Gov. Maura Healey’s $3.5 billion plan to reinvigorate the state’s business climate want the benefits to stretch beyond the Boston metropolitan area.
Worcester’s biggest life sciences development site could get a lot bigger thanks to a proposal the city’s Planning Board is expected to consider next month.
Massachusetts life science industry is expanding into new submarkets and creating fast-growing job clusters from Boston to Worcester despite a more challenging funding climate.
If Massachusetts wants to remain on top in biotech, a way to do so is to invest in biomanufacturing and think beyond the life sciences hubs of Boston and Cambridge.
Biomanufacturing was supposed to be a big part of the next “Massachusetts Miracle,” but tenant requirements have been cut in half in the last year. But its believers have faith in the sector’s durability over the long term.
The Newburyport biomanufacturing plant that exploded early today and sent four people to the hospital has a history of safety and environmental law violations.
Legislators’ decision to approve 3.5 million square feet of development at Devens is set to bring a new pulse of growth to the former Army base-turned-business-park.
President Joe Biden’s new executive order will expand biomanufacturing in the U.S., reverse the decades-long migration of critical manufacturing abroad and give Massachusetts a big boost at the same time.
President Joe Biden is launching a new initiative that could generate more demand in a growing subsector of Boston’s life science real estate industry.
Greater Boston towers above the competition among U.S. metros in its lab development pipeline, while remaining the nation’s top talent cluster in the industry.
Boston-based Davis Cos. is the reported winning bidder for ExxonMobil’s 95-acre tank farm in Everett, advancing plans for a large redevelopment of the city’s industrial waterfront.
There’s no hope of bringing the auto industry back to Somerville’s Assembly Square, while the textile industry bailed for sunnier climes nearly a century ago. But Massachusetts may yet see a manufacturing renaissance from a possible tenfold increase in biomanufacturing real estate.
Demand is simply outstripping supply for all types of industrial space, including old-fashioned light-manufacturing space, and there’s no end in sight despite recent facility conversions and new construction of millions of square feet of supply.